|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/4545 | (2006.01) |
| A61K 31/4545 | (2013.01) | ||
| A61P 3/04 | (2006.01) | ||
| A61P 3/04 | (2018.01) | ||
| A61P 3/10 | (2006.01) | ||
| A61P 3/10 | (2018.01) | ||
| A61K 9/20 | (2006.01) | ||
| A61K 9/2054 | (2013.01) | ||
| A61K 9/2059 | (2013.01) | ||
| A61K 9/2086 | (2013.01) |
| (11) | Patento numeris | 4125896 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 21714685.1 |
| Europos patento paraiškos padavimo data | 2021-03-24 | |
| (97) | Europos patento paraiškos paskelbimo data | 2023-02-08 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2025-05-07 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/IB2021/052430 |
| Data | 2021-03-24 |
| (87) | Numeris | WO 2021/191812 |
| Data | 2021-09-30 |
| (30) | Numeris | Data | Šalis |
| 202063000787 P | 2020-03-27 | US | |
| 202063126113 P | 2020-12-16 | US | |
| 202163135870 P | 2021-01-11 | US |
| (72) |
LEE, Kai Teck , GB
MANTHENA, Sweta , US
SAXENA, Aditi Rao , US
|
| (73) |
Pfizer Inc. ,
66 Hudson Boulevard East, New York, NY 10001-2192,
US
|
| (54) | TREATMENT OF TYPE 2 DIABETES WITH 2-[(4-{6-[(4-CYANO-2-FLUOROBENZYL)OXY]PYRIDIN-2-YL} PIPERIDIN-1-YL)METHYL]-1-[(2S)-OXETAN-2-YLMETHYL]-1H-BENZIMIDAZOLE-6-CARBOXYLIC ACID OR A PHARMACEUTICALLY SALT THEREOF |
| TREATMENT OF TYPE 2 DIABETES WITH 2-[(4-{6-[(4-CYANO-2-FLUOROBENZYL)OXY]PYRIDIN-2-YL} PIPERIDIN-1-YL)METHYL]-1-[(2S)-OXETAN-2-YLMETHYL]-1H-BENZIMIDAZOLE-6-CARBOXYLIC ACID OR A PHARMACEUTICALLY SALT THEREOF |